SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-034440
Filing Date
2017-06-27
Accepted
2017-06-27 17:00:57
Documents
3
Period of Report
2017-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v469810_8k.htm 8-K 18114
2 EXHIBIT 10.1 v469810_ex10-1.htm EX-10.1 5251
3 EXHIBIT 10.2 v469810_ex10-2.htm EX-10.2 5344
  Complete submission text file 0001144204-17-034440.txt   30060
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 17932995
SIC: 2834 Pharmaceutical Preparations